Cargando…

An overview on medicinal plants used for combating coronavirus: Current potentials and challenges

Worldwide, Severe acute respiratory syndrome Coronavirus (SARS-CoV-2) pandemic crisis, causing many morbidities, mortality, and devastating impact on economies, so the current outbreak of the CoV-2 is a major concern for global health. The infection spread quickly and caused chaos in many countries...

Descripción completa

Detalles Bibliográficos
Autores principales: Abou Baker, Doha H., Hassan, Emad M., El Gengaihi, Souad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198795/
https://www.ncbi.nlm.nih.gov/pubmed/37251276
http://dx.doi.org/10.1016/j.jafr.2023.100632
_version_ 1785044811986763776
author Abou Baker, Doha H.
Hassan, Emad M.
El Gengaihi, Souad
author_facet Abou Baker, Doha H.
Hassan, Emad M.
El Gengaihi, Souad
author_sort Abou Baker, Doha H.
collection PubMed
description Worldwide, Severe acute respiratory syndrome Coronavirus (SARS-CoV-2) pandemic crisis, causing many morbidities, mortality, and devastating impact on economies, so the current outbreak of the CoV-2 is a major concern for global health. The infection spread quickly and caused chaos in many countries around the world. The slow discovery of CoV-2 and the limited treatment options are among the main challenges. Therefore, the development of a drug that is safe and effective against CoV-2 is urgently needed. The present overview briefly summarizes CoV-2 drug targets ex: RNA-dependent RNA polymerase (RdRp), papain-like protease (PLpro), 3-chymotrypsin-like protease (3CLpro), transmembrane serine protease enzymes (TMPRSS2), angiotensin-converting enzyme 2 (ACE2), structural protein (N, S, E, and M), and virulence factors (NSP1, ORF7a, and NSP3c) for which drug design perspective can be considered. In addition, summarize all anti-COVID-19 medicinal plants and phytocompounds and their mechanisms of action to be used as a guide for further studies.
format Online
Article
Text
id pubmed-10198795
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-101987952023-05-22 An overview on medicinal plants used for combating coronavirus: Current potentials and challenges Abou Baker, Doha H. Hassan, Emad M. El Gengaihi, Souad J Agric Food Res Article Worldwide, Severe acute respiratory syndrome Coronavirus (SARS-CoV-2) pandemic crisis, causing many morbidities, mortality, and devastating impact on economies, so the current outbreak of the CoV-2 is a major concern for global health. The infection spread quickly and caused chaos in many countries around the world. The slow discovery of CoV-2 and the limited treatment options are among the main challenges. Therefore, the development of a drug that is safe and effective against CoV-2 is urgently needed. The present overview briefly summarizes CoV-2 drug targets ex: RNA-dependent RNA polymerase (RdRp), papain-like protease (PLpro), 3-chymotrypsin-like protease (3CLpro), transmembrane serine protease enzymes (TMPRSS2), angiotensin-converting enzyme 2 (ACE2), structural protein (N, S, E, and M), and virulence factors (NSP1, ORF7a, and NSP3c) for which drug design perspective can be considered. In addition, summarize all anti-COVID-19 medicinal plants and phytocompounds and their mechanisms of action to be used as a guide for further studies. Published by Elsevier B.V. 2023-09 2023-05-20 /pmc/articles/PMC10198795/ /pubmed/37251276 http://dx.doi.org/10.1016/j.jafr.2023.100632 Text en © 2023 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Abou Baker, Doha H.
Hassan, Emad M.
El Gengaihi, Souad
An overview on medicinal plants used for combating coronavirus: Current potentials and challenges
title An overview on medicinal plants used for combating coronavirus: Current potentials and challenges
title_full An overview on medicinal plants used for combating coronavirus: Current potentials and challenges
title_fullStr An overview on medicinal plants used for combating coronavirus: Current potentials and challenges
title_full_unstemmed An overview on medicinal plants used for combating coronavirus: Current potentials and challenges
title_short An overview on medicinal plants used for combating coronavirus: Current potentials and challenges
title_sort overview on medicinal plants used for combating coronavirus: current potentials and challenges
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198795/
https://www.ncbi.nlm.nih.gov/pubmed/37251276
http://dx.doi.org/10.1016/j.jafr.2023.100632
work_keys_str_mv AT aboubakerdohah anoverviewonmedicinalplantsusedforcombatingcoronaviruscurrentpotentialsandchallenges
AT hassanemadm anoverviewonmedicinalplantsusedforcombatingcoronaviruscurrentpotentialsandchallenges
AT elgengaihisouad anoverviewonmedicinalplantsusedforcombatingcoronaviruscurrentpotentialsandchallenges
AT aboubakerdohah overviewonmedicinalplantsusedforcombatingcoronaviruscurrentpotentialsandchallenges
AT hassanemadm overviewonmedicinalplantsusedforcombatingcoronaviruscurrentpotentialsandchallenges
AT elgengaihisouad overviewonmedicinalplantsusedforcombatingcoronaviruscurrentpotentialsandchallenges